1. Home
  2. HLX vs MLTX Comparison

HLX vs MLTX Comparison

Compare HLX & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Helix Energy Solutions Group Inc.

HLX

Helix Energy Solutions Group Inc.

HOLD

Current Price

$8.56

Market Cap

1.2B

Sector

Energy

ML Signal

HOLD

Logo MoonLake Immunotherapeutics

MLTX

MoonLake Immunotherapeutics

HOLD

Current Price

$15.51

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HLX
MLTX
Founded
1979
2021
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
HLX
MLTX
Price
$8.56
$15.51
Analyst Decision
Strong Buy
Buy
Analyst Count
2
9
Target Price
$10.50
$22.22
AVG Volume (30 Days)
2.0M
2.3M
Earning Date
02-23-2026
02-25-2026
Dividend Yield
N/A
N/A
EPS Growth
497.36
N/A
EPS
0.28
N/A
Revenue
$1,312,445,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$4.96
N/A
P/E Ratio
$30.30
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.52
$5.95
52 Week High
$8.90
$62.75

Technical Indicators

Market Signals
Indicator
HLX
MLTX
Relative Strength Index (RSI) 67.24 48.42
Support Level $8.03 $14.47
Resistance Level $8.53 $16.69
Average True Range (ATR) 0.32 0.86
MACD 0.05 -0.23
Stochastic Oscillator 78.91 25.69

Price Performance

Historical Comparison
HLX
MLTX

About HLX Helix Energy Solutions Group Inc.

Helix Energy Solutions Group Inc is an offshore energy services company. It provides specialty services to the offshore energy industry, with an emphasis on well intervention and robotics operations. Helix provides services in deep water in the Gulf of Mexico, Brazil, the North Sea, Asia Pacific and West Africa regions. It has four segments: Well Intervention, Robotics, Shallow Water Abandonment and Production Facilities. the Well Intervention segment includes vessels and equipment used to perform well intervention services in the Gulf of Mexico, the North Sea and Brazil. It derives the majority of its revenue from the U.S.

About MLTX MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.

Share on Social Networks: